Literature DB >> 19494824

Treatment of chronic hepatitis C in a slow responder: a case for extended therapy.

Paul J Gaglio1.   

Abstract

BACKGROUND: A 49-year-old white man presented to his primary-care clinic with fatigue and poor concentration. He had an enlarged liver with a minimally tender edge and was subsequently referred to our liver clinic. INVESTIGATIONS: Physical examination, laboratory investigations (including tests for HCV-RNA, antibodies to hepatitis B surface and core antigens, and HBV-DNA), and liver biopsy. DIAGNOSIS: The patient had chronic hepatitis C infection and was a slow responder to treatment. MANAGEMENT: Administration of pegylated interferon alpha2b plus ribavirin for 72 weeks. Escitalopram was given to manage his depression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19494824     DOI: 10.1038/nrgastro.2009.65

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN: 1759-5045            Impact factor:   46.802


  14 in total

1.  Scope of worldwide hepatitis C problem.

Authors:  Robert S Brown; Paul J Gaglio
Journal:  Liver Transpl       Date:  2003-11       Impact factor: 5.799

2.  Diagnosis, management, and treatment of hepatitis C.

Authors:  Doris B Strader; Teresa Wright; David L Thomas; Leonard B Seeff
Journal:  Hepatology       Date:  2004-04       Impact factor: 17.425

3.  Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40 KD)/ribavirin.

Authors:  Peter Ferenci; Michael W Fried; Mitchell L Shiffman; Coleman I Smith; George Marinos; Fernando L Gonçales; Dieter Häussinger; Moises Diago; Giampero Carosi; Daniel Dhumeaux; Antonio Craxì; Monique Chaneac; K Rajender Reddy
Journal:  J Hepatol       Date:  2005-09       Impact factor: 25.083

Review 4.  Classification of chronic viral hepatitis: a need for reassessment.

Authors:  P J Scheuer
Journal:  J Hepatol       Date:  1991-11       Impact factor: 25.083

5.  Peginterferon-alfa2a plus ribavirin for 48 versus 72 weeks in patients with detectable hepatitis C virus RNA at week 4 of treatment.

Authors:  José M Sánchez-Tapias; Moisés Diago; Pedro Escartín; Jaime Enríquez; Manuel Romero-Gómez; Rafael Bárcena; Javier Crespo; Raúl Andrade; Eva Martínez-Bauer; Ramón Pérez; Milagros Testillano; Ramón Planas; Ricard Solá; Manuel García-Bengoechea; Javier Garcia-Samaniego; Miguel Muñoz-Sánchez; Ricardo Moreno-Otero
Journal:  Gastroenterology       Date:  2006-08       Impact factor: 22.682

6.  Extended treatment duration for hepatitis C virus type 1: comparing 48 versus 72 weeks of peginterferon-alfa-2a plus ribavirin.

Authors:  Thomas Berg; Michael von Wagner; Samer Nasser; Christoph Sarrazin; Tobias Heintges; Tilman Gerlach; Peter Buggisch; Tobias Goeser; Jens Rasenack; Gerd R Pape; Wolfgang E Schmidt; Birgit Kallinowski; Hartwig Klinker; Ulrich Spengler; Peter Martus; Ulrich Alshuth; Stefan Zeuzem
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

7.  Incidence of neutropenia and infections during combination treatment of chronic hepatitis C with pegylated interferon alfa-2a or alfa-2b plus ribavirin.

Authors:  M G Antonini; S Babudieri; I Maida; C Baiguera; B Zanini; L Fenu; G Dettori; D Manno; M S Mura; G Carosi; M Puoti
Journal:  Infection       Date:  2008-05-03       Impact factor: 3.553

8.  Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C.

Authors:  Gary L Davis; John B Wong; John G McHutchison; Michael P Manns; Joann Harvey; Janice Albrecht
Journal:  Hepatology       Date:  2003-09       Impact factor: 17.425

Review 9.  Thrombocytopenia associated with chronic liver disease.

Authors:  Nezam Afdhal; John McHutchison; Robert Brown; Ira Jacobson; Michael Manns; Fred Poordad; Babette Weksler; Rafael Esteban
Journal:  J Hepatol       Date:  2008-03-31       Impact factor: 25.083

10.  Treatment extension to 72 weeks of peginterferon and ribavirin in hepatitis c genotype 1-infected slow responders.

Authors:  Brian L Pearlman; Carole Ehleben; Sophia Saifee
Journal:  Hepatology       Date:  2007-12       Impact factor: 17.425

View more
  1 in total

1.  Delayed viral clearance of chronic hepatitis C in patients after treatment failure.

Authors:  Su Hyun Cho; Sung Wook Lee; Seok Reyol Choi; Sang Young Han; Myung Hwan Roh; Jong Hoon Lee; Jin Seok Jang; Yang Hyun Baek; Su Young Kim
Journal:  Gut Liver       Date:  2011-03-16       Impact factor: 4.519

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.